Form D · Other
Medrio, Inc.
San Francisco, CA · CIK 0001533827
Offering snapshot reported May 26, 2017 · SEC filing
- Reported sold
- $25M Offering amount: $30M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 12, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 26, 2017 | Initial | $24,999,997 | No comparison | 2 | SEC filing |
| Oct 31, 2011 | Initial | $2,026,196 | No comparison | 33 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-287590
Source: Form D, filed May 26, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ryan Drant | Director |
| Doug Engfer | Director |
| Dave Lipscomb | Director |
| Michael Novotny | Director, Executive |
| Mike Novotny | Director, Executive |
| Richard Scheller | Director |
| Bradley Sloan | Director |
Issuer details
Industry: Other (See others in industry)
Address:
345 California Street Suite 325
San Francisco, CA, 94104
San Francisco, CA, 94104